SCHEMBL7845236

SCHEMBL7845236

CCCCC(CCCCCO)NS(=O)(=O)c1ccc(F)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FFAR1 O14842 1/20 0.44
▸ FFAR4 Q5NUL3 1/20 0.44
▸ ALDH1A1 P00352 4/20 0.43
▸ MEN1 O00255 2/20 0.43
▸ KMT2A Q03164 2/20 0.43
▸ PKM P14618 1/20 0.43
▸ MMP1 P03956 3/20 0.41
▸ MMP2 P08253 3/20 0.41
▸ MMP9 P14780 3/20 0.41
▸ MMP13 P45452 3/20 0.41
▸ MMP3 P08254 2/20 0.41
▸ MMP7 P09237 2/20 0.41
▸ HTT P42858 1/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ CA2 P00918 3/20 0.41
▸ CA1 P00915 2/20 0.41
▸ MMP8 P22894 2/20 0.41
▸ LMNA P02545 2/20 0.40
▸ MMP14 P50281 1/20 0.40
▸ SLC1A3 P43003 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20988329 0.78 CA2 (0.57) FFAR1FFAR4ALDH1A1MEN1KMT2A
SCHEMBL2228232 0.77 SMN1; SMN2 (0.58) ALDH1A1PKMMMP1MMP2MMP9
SCHEMBL30887502 0.77 CA2 (0.60) ALDH1A1MMP1MMP2MMP9MMP13
SCHEMBL1727771 0.76 SLC1A3 (0.50) ALDH1A1MEN1KMT2APKMMMP1
SCHEMBL2216960 0.76 SLC1A3 (0.50) ALDH1A1MEN1KMT2APKMMMP1
SCHEMBL7373802 0.76 MMP9 (0.57) MMP1MMP2MMP9MMP13MMP3
SCHEMBL10482884 0.75 CA2 (0.57) ALDH1A1MMP1MMP2MMP9MMP13
SCHEMBL10482887 0.75 CA2 (0.57) ALDH1A1MMP1MMP2MMP9MMP13
SCHEMBL1287356 0.75 CA1 (0.53) FFAR1FFAR4ALDH1A1MEN1KMT2A
SCHEMBL12508301 0.74 ALOX5AP (0.46) ALDH1A1MMP1MMP2MMP9MMP13

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1155007-A2 1,2-BENZOTHIAZEPINES FOR THE TREATMENT OF HYPERLIPIDEMIC DISEASES G.D. Searle LLC (US) 2001-11-21 — — EP disclosed
WO-2000047568-A2 1,2-BENZOTHIAZEPINES FOR THE TREATMENT OF HYPERLIPIDEMIC DISEASES G.D. SEARLE LLC (US) 2000-08-17 — — WO disclosed
Send feedback